Lite Strategy Statistics
NASDAQ: LITSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.27-0.14 (-9.93%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 1.18 -7.09%
Lite Strategy by the numbers
Lite Strategy has a market capitalization of $38.6 million based on 30.41M shares outstanding. With trailing EPS of $-2.06, Lite Strategy is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.0% above its 50-day average and 14.0% above its 200-day average.
Average daily trading volume is 448.62K shares, or about $569,751 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LITS valuation vs. peer median
| Metric | LITS | Peer median | Difference |
|---|---|---|---|
| Market cap | $38.62M | $37.52M | +3% |
| Avg. volume | 448.62K | 261.59K | +72% |
Peer median across 8 companies: IBO, FLNA, IXHL, NNVC, CPHI, VERU, BCTX, ATNM.
Valuation
- Market cap
- $38.62M
- EPS (TTM)
- $-2.06
- Shares outstanding
- 30.41M
Price and trading
- Previous close
- 1.41
- Open
- 1.30
- Day range
- 1.27 – 1.33
- 52-week range
- 0.69 – 2.97
- 52-week change
- -48.16%
- Beta
- —
- Volume
- 780.32K
- Average volume
- 448.62K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 29, 2026
Additional statistics
- Market Cap
- 38.62M
- Eps
- -2.06
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.97
- Week52 Low
- 0.69
- Avg Volume
- 448.62K
- Shares Outstanding
- 30.41M
- Ma50
- 1.09
- Ma200
- 1.11
- Earnings Date
- Sep 29, 2026
- Pct From52w High
- -57.24%
- Pct From52w Low
- 84.06%